Suits Surge Against Makers of Anti-Psych Drug Seroquel

Plaintiffs filed over 350 products liability cases last month in Delaware state court against AstraZeneca Pharmaceuticals over the anti-psychotic drug Seroquel, which is more than the total number of cases filed in AstraZeneca's home state in the last two years. A defense observer thinks that plaintiffs counsel may be trying to force the company into an early settlement of the Delaware cases and to avoid the federal multidistrict litigation. But a defense attorney says AstraZeneca has no plans to settle.

This article requires premium access

This article requires premium access to Law.com. Please sign in or subscribe to read the full text.